FLT3 ligand treatment attenuates T cell dysfunction and improves survival in a murine model of burn wound sepsis

Shock

Volumn 47, Issue 1, 2017, Pages 40-51

  Patil, Naeem K ^a   Bohannon, Julia K ^a   Luan, Liming ^a   Guo, Yin ^a   Fensterheim, Benjamin ^a   Hernandez, Antonio ^a   Wang, Jingbin ^a   Sherwood, Edward R ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Burn; Dendritic cells; Fms like tyrosine kinase 3 (Flt3) ligand; Macrophages; Sepsis; Tcells; Wound infection

Indexed keywords

FLT3 LIGAND; GAMMA INTERFERON; PROGRAMMED DEATH 1 RECEPTOR; CD28 ANTIGEN; FLT3 LIGAND PROTEIN; MEMBRANE PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; BACTERIAL CLEARANCE; BURN INFECTION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL EXPANSION; CONFERENCE PAPER; CONTROLLED STUDY; DENDRITIC CELL; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL; INNATE IMMUNITY; LEUKOCYTE; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MALE; MOUSE; NEUTROPHIL; NEUTROPHIL COUNT; NONHUMAN; PROTEIN EXPRESSION; PSEUDOMONAS AERUGINOSA; SEPSIS; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; UPREGULATION; ANIMAL; BAGG ALBINO MOUSE; BURN; DISEASE MODEL; DRUG EFFECTS; METABOLISM;

ANIMALS; BURNS; CD28 ANTIGENS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; INTERFERON-GAMMA; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; SEPSIS; T-LYMPHOCYTES;

EID: 84979567298     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0000000000000688     Document Type: Conference Paper

References (35)

1. Williams FN, Herndon DN, Hawkins HK, Lee JO, Cox RA, Kulp GA, Finnerty CC, Chinkes DL, Jeschke MG: The leading causes of death after burn injury in a single pediatric burn center. Crit Care 13(6):R183, 2009.
2. Patil NK, Luan L, Bohannon JK, Guo Y, Hernandez A, Fensterheim B, Sher-wood ER: IL-15 superagonist expands mCD8- T, NK and NKT cells after burn injury but fails to improve outcome during burn wound infection. PLoS One 11(2):e0148452, 2016.
3. Valvis SM, Waithman J, Wood FM, Fear MW, Fear VS: The immune response to skin trauma is dependent on the etiology of injury in a mouse model of burn and excision. J Invest Dermatol 135(8):2119-2128, 2015.
4. Fukuzuka K, Edwards CK 3rd, Clare-Salzler M, Copeland EM 3rd, Moldawer LL, Mozingo DW: Glucocorticoid-induced, caspase-dependent organ apoptosis early after burn injury. Am J Physiol Regul Integr Comp Physiol 278(4):R1005-R1018, 2000.
5. O'Sullivan ST, Lederer JA, Horgan AF, Chin DH, Mannick JA, Rodrick ML: Major injury leads topredominanceof the Thelper-2 lymphocyte phenotype and diminished interleukin-12 production associated with decreased resistance to infection. Ann Surg 222(4):482-490, 1995.
6. Shen H, de Almeida PE, Kang KH, Yao P, Chan CW: Burn injury triggered dysfunction in dendritic cell response to TLR9 activation and resulted in skewed T cell functions. PLoS One 7(11):e50238, 2012.
7. Hotchkiss RS, Coopersmith CM, McDunn JE, Ferguson TA: The sepsis seesaw: tilting toward immunosuppression. Nat Med 15(5):496-497, 2009.
8. Patil NK, Parajuli N, MacMillan-Crow LA, Mayeux PR: Inactivation of renal mitochondrial respiratory complexes and manganese superoxide dismutase during sepsis: mitochondria-targeted antioxidant mitigates injury. Am J Physiol Renal Physiol 306(7):F734-F743, 2014.
9. Wang Z, Sims CR, Patil NK, Gokden N, Mayeux PR: Pharmacologic targeting of sphingosine-1-phosphate receptor 1 improves the renal microcirculation during sepsis in the mouse. J Pharmacol Exp Ther 352(1):61-66, 2015.
10. Holthoff JH, Wang Z, Patil NK, Gokden N, Mayeux PR: Rolipram improves renal perfusion and function during sepsis in the mouse. J Pharmacol Exp Ther 347(2):357-364, 2013.
11. Wodnar-Filipowicz A: Flt3 ligand: role in control of hematopoietic and immune functions of the bone marrow. News Physiol Sci 18:247-251, 2003.
12. Maraskovsky E, Daro E, Roux E, Teepe M, Maliszewski CR, Hoek J, Caron D, Lebsack ME, McKenna HJ: In vivo generation of human dendritic cell subsets by Flt3 ligand. Blood 96(3):878-884, 2000.
13. Bohannon J, Cui W, Cox R, Przkora R, Sherwood E, Toliver-Kinsky T: Prophylactic treatment with fms-like tyrosine kinase-3 ligand after burn injury enhances global immune responses to infection. J Immunol 180(5):3038-3048, 2008.
14. Bohannon J, Cui W, Sherwood E, Toliver-Kinsky T: Dendritic cell modification of neutrophil responses to infection after burn injury. J Immunol 185(5): 2847-2853, 2010.
15. Bohannon J, Fang G, Cui W, Sherwood E, Toliver-Kinsky T: Fms-like tyrosine kinase-3 ligand alters antigen-specific responses to infections after severe burn injury. Shock 32(4):435-441, 2009.
16. Bohannon JK, Luan L, Hernandez A, Afzal A, Guo Y, Patil NK, Fensterheim B, Sherwood ER: RoleofG-CSFinmonophosphoryllipid A-mediated augmentation of neutrophil functions after burn injury. J Leukoc Biol 99(4):629-640, 2015.
17. Guo Y, Luan L, Rabacal W, Bohannon JK, Fensterheim BA, Hernandez A, Sherwood ER: IL-15 superagonist-mediated immunotoxicity: role of NK cells and IFN-gamma. J Immunol 195(5):2353-2364, 2015.
18. Fitzwater J, Purdue GF, Hunt JL, O'Keefe GE: The risk factors and time course of sepsis and organ dysfunction after burn trauma. J Trauma 54(5):959-966, 2003.
19. Lamoreaux L, Roederer M, Koup R: Intracellular cytokine optimization and standard operating procedure. Nat Protoc 1(3):1507-1516, 2006.
20. Chen L, Flies DB: Molecular mechanisms of T cell co-stimulation and co-inhibition. Nat Rev Immunol 13(4):227-242, 2013.
21. Huang X, Chen Y, Chung CS, Yuan Z, Monaghan SF, Wang F, Ayala A: Identification of B7-H1 as a novel mediator of the innate immune/proinflam-matory response as well as a possible myeloid cell prognostic biomarker in sepsis. J Immunol 192(3):1091-1099, 2014.
22. Monaghan SF, Thakkar RK, Tran ML, Huang X, Cioffi WG, Ayala A, Heffernan DS: Programmed death 1 expression as a marker for immune and physiological dysfunction in the critically ill surgical patient. Shock 38(2):117-122, 2012.
23. Chang K, Svabek C, Vazquez-Guillamet C, Sato B, Rasche D, Wilson S, Robbins P, Ulbrandt N, Suzich J, Green J, et al.: Targeting the programmed cell death 1: programmed cell death ligand 1 pathway reverses T cell exhaustion in patients with sepsis. Crit Care 18(1):R3, 2014.
24. Zhang Y, Zhou Y, Lou J, Li J, Bo L, Zhu K, Wan X, Deng X, Cai Z: PD-L1 blockade improves survival in experimental sepsis by inhibiting lymphocyte apoptosis and reversing monocyte dysfunction. Crit Care 14(6):R220, 2010.
25. Sansom DM, Manzotti CN, Zheng Y: What's the difference between CD80 and CD86? Trends Immunol 24(6):314-319, 2003.
26. Williams FN, Herndon DN, Hawkins HK, Lee JO, Cox RA, Kulp GA, Finnerty CC, Chinkes DL, Jeschke MG: The leading causes of death after burn injury in a single pediatric burn center. Critical care 13(6):R183, 2009.
27. Mann EA, Baun MM, Meininger JC, Wade CE: Comparison of mortality associated with sepsis in the burn, trauma, and general intensive care unit patient: a systematic review of the literature. Shock 37(1):4-16, 2012.
28. Unsinger J, McGlynn M, Kasten KR, Hoekzema AS, Watanabe E, Muenzer JT, McDonough JS, Tschoep J, Ferguson TA, McDunn JE, et al.: IL-7 promotes T cell viability, trafficking, and functionality and improves survival in sepsis. J Immunol 184(7):3768-3779, 2010.
29. Shindo Y, Unsinger J, Burnham CA, Green JM, Hotchkiss RS: Interleukin-7 and anti-programmed cell death 1 antibody have differing effects to reverse sepsis-induced immunosuppression. Shock 43(4):334-343, 2015.
30. Acuto O, Michel F: CD28-mediated co-stimulation: a quantitative support for TCR signalling. Nat Rev Immunol 3(12):939-951, 2003.
31. Boomer JS, To K, Chang KC, Takasu O, Osborne DF, Walton AH, Bricker TL, Jarman SD 2nd, Kreisel D, Krupnick AS, et al.: Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA 306(23):2594-2605, 2011.
32. Wang L, Zhu J, Shan S, Qin Y, Kong Y, Liu J, Wang Y, Xie Y: Repression of interferon-gamma expression in T cells by Prospero-related homeobox protein. Cell Res 18(9):911-920, 2008.
33. Murphey ED, Lin CY, McGuire RW, Toliver-Kinsky T, Herndon DN, Sherwood ER: Diminished bacterial clearance is associated with decreased IL-12 and interferon-gamma production but a sustained proinflammatory response in a murine model of postseptic immunosuppression. Shock 21(5):415-425, 2004.
34. Villadangos JA, Schnorrer P: Intrinsic and cooperative antigen-presenting functions of dendritic-cell subsets in vivo. Nat Rev Immunol 7(7):543-555, 2007.
35. Guignant C, Lepape A, Huang X, Kherouf H, Denis L, Poitevin F, Malcus C, Cheron A, Allaouchiche B, Gueyffier F, et al.: Programmed death-1 levels correlate with increased mortality, nosocomial infection and immune dysfunctions in septic shock patients. Crit Care 15(2):R99, 2011.